<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-997I0VS7</identifier><date>2019</date><creator>Jazbec, Janez</creator><creator>Mlinarič-Raščan, Irena</creator><creator>Šmid, Alenka</creator><relation>documents/doc/9/URN_NBN_SI_doc-997I0VS7_001.pdf</relation><relation>documents/doc/9/URN_NBN_SI_doc-997I0VS7_001.txt</relation><format format_type="issue">5/6</format><format format_type="volume">88</format><format format_type="type">article</format><format format_type="extent">str. 235-248</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID_HOST">4781937</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-997I0VS7</identifier><language>slv</language><publisher>Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">akutna limfoblastna levkemija</subject><subject language_type_id="slv">farmakogenetika</subject><subject language_type_id="slv">Levkemija</subject><subject language_type_id="slv">posamezniku prilagojeno zdravljenje</subject><subject language_type_id="slv">tiopurini</subject><subject language_type_id="slv">tiopurin-S-metiltransferaza</subject><title>Farmakogenetski označevalci v terapiji akutne limfoblastne levkemije pri otrocih</title><title>Pharmacogenetic markers in the therapy of childhood acute lymphoblastic leukemia</title></Record>